Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1994;20(1):51-7.
doi: 10.1007/BF02425058.

A new paediatric metabolic monitor

W Weyland  1 , A Weyland, U Fritz, K Redecker, F B Ensink, U Braun
Affiliations
Comparative Study

A new paediatric metabolic monitor

W Weyland et al. Intensive Care Med. 1994.

Abstract

Objective: A paediatric option for the measurement of VO2 and VCO2 (20 to 150 ml/min) has recently been introduced for the adult Deltatrac metabolic monitor (Datex Instrumentarium, Finland) to use in ventilated and spontaneously breathing children. This paper describes a laboratory validation of the paediatric option for ventilated children with regard to the influence of respiratory variables.

Design: Respiratory variables were varied within the following ranges: FIO2 0.21-0.8, FIO2-FEO2 (DFO2) 0.01-0.05, FECO2 0.01-0.05, VE 300-6000 ml/min, VT 8-300 ml, RR 10-50/min, P(aw) 10-60 mbar, relative humidity 10% and 60%, and resulted in 107 test situations.

Setting: Gas exchange was simulated by injection of nitrogen and CO2 at a RQ close to 1.

Patients or participants: Different situations of paediatric patients ventilated in controlled mode were simulated on a gas injection model.

Interventions: Respiratory and metabolic variables were varied independently to result in a range of 8 to 210 ml/min of VO2 and VCO2.

Measurements and results: Reference measurements were carried out by mass spectrometry and wet gas spirometry. The mean VCO2 difference for all tests ranging from 20 ml/min to 210 ml/min was -2.4% (2SD = +/- 12%). The respective VO2 difference was -3.2% (2SD = +/- 23%). Measurement agreement for VO2 in neonatal respirator treatment (20-50 ml/min) compared to older children (50-210 ml/min) showed a mean difference of -3.9% (2SD = +/- 26%) versus -2.8% (2SD = +/- 20%). The respective differences for VCO2 were -7.1% (2SD = +/- 7%) versus +0.4% (2SD = +/- 10%). The mean difference for VO2 as well as VCO2 indicated a high systematic agreement of both methods. The variability (+/- 2SD) in VCO2 measurement is acceptable for all applications. The overall variability in VO2 measurement (2SD = +/- 23%) can be reduced by exclusion of all tests with a FECO2 and DFO2 below 0.03. This results in a mean difference of -3.2% (2SD = +/- 13.7%).

Conclusion: Within this limitation the paediatric measurement option seems to introduce a valuable method for clinical application in paediatric intensive care medicine.

PubMed Disclaimer

References

    1. Anaesthesist. 1992 Apr;41(4):210-7 - PubMed
    1. Int J Clin Monit Comput. 1987;4(3):167-77 - PubMed
    1. JPEN J Parenter Enteral Nutr. 1990 Mar-Apr;14(2):216-21 - PubMed
    1. Am J Clin Nutr. 1991 Jul;54(1):30-4 - PubMed
    1. Lancet. 1986 Feb 8;1(8476):307-10 - PubMed

Publication types